Epigral has informed that pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31st December, 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated 2nd January, 2025, Integrated Filing (Financial) for the third quarter and nine months ended on 31st December, 2024 is enclosed.
The above information is a part of company’s filings submitted to BSE.